MedPath

Effect van MCT inname in gezonde persone

Recruiting
Conditions
long-chain fatty acid oxidation disorders, CPT2D, LCHADD, MTPD, VLCADD
Registration Number
NL-OMON25246
Lead Sponsor
Amsterdam UMC AMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
4
Inclusion Criteria

Healthy male

- Age 18+

Exclusion Criteria

- Hypertriglyceridemia

- Dyslipidaemia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
• Quantification of oxidation rate of MCT, calculated from 13C enrichment of breath CO2<br /><br>• Testing if MCT is elongated by measuring 13C enrichment of C12-22 of plasma FFA, TG, PL, CE, VLDL, LDL and HDL.
Secondary Outcome Measures
NameTimeMethod
• Minimum duration of fasting that enables us to detect appropriate levels of LCT and free fatty acids in plasma.<br /><br>• Duration of oral MCT administration to accurately measure MCT elongation to plasma LCT.
© Copyright 2025. All Rights Reserved by MedPath